Skip to main content
Top

Journal of Endocrinological Investigation

Issue 12/2008

Content (21 Articles)

Editorial

Editorial

Ezio Ghigo

In Memoriam

In Memoriam

G. Frajese

Original Articles

Tamoxifen inhibits transforming growth factor-α gene expression in human breast carcinoma samples treated with triiodothyronine

S. J. Conde, R. A. M. Luvizotto, M. T. Síbio, M. L. H. Katayama, M. M. Brentani, C. R. Nogueira

Original Articles

Craniofacial abnormalities, obesity, and hormonal alterations have similar effects in magnitude on the development of nocturnal hypoxemia in patients with acromegaly

M. P. Rodrigues, L. A. Naves, L. A. Casulari, C. M. Silva, W. D. Paula, M. T. Cabral, R. R. Araujo, C. A. Viegas

Original Articles

Cardiovascular risk engines can help in selecting patients to be evaluated by dynamic penile color doppler ultrasound

G. Corona, E. Mannucci, A. D. Fisher, F. Lotti, E. Bandini, L. Vignozzi, G. Balercia, F. Paggi, L. Petrone, G. Forti, M. Maggi

Original Articles

Prevalence of post-partum thyroiditis in Liguria (Italy): An observational study

U. Filippi, R. Brizzolara, D. Venuti, A. Cesarone, V. A. Maritati, M. Podestà, W. F. Yung, L. C. Bottaro, A. Orselli, A. Chiappori, M. Schiavo, M. Caputo, S. Bonassi, M. Bagnasco

Original Articles

Effect of very low LDL-cholesterol on cortisol synthesis

K. Sezer, R. Emral, D. Corapcioglu, R. Gen, E. Akbay

Original Articles

Involvement of regulatory elements on corticotropin-releasing factor gene promoter in nypothalamic 4B cells

K. Kageyama, K. Hanada, S. Takayasu, Y. Iwasaki, S. Sakihara, T. Nigawara, T. Suda

Original Articles

Correlation between adiponectin polymorphisms and non-alcoholic fatty liver disease with or without metabolic syndrome in Chinese population

Z. L. Wang, B. Xia, U. Shrestha, L. Jiang, C. W. Ma, Q. Chen, H. Chen, Z. G. Hu

Original Articles

Polymorphisms of steroid 5- α- reductase type I (SRD5A1) gene are associated to peripheral arterial disease

S. S. Signorelli, V. Barresi, N. Musso, M. Anzaldi, E. Croce, V. Fiore, D. F. Condorelli

Original Articles

High-normal fasting glucose levels are associated with increased prevalence of impaired glucose tolerance in obese children

A. Grandone, A. Amato, C. Luongo, N. Santoro, L. Perrone, E. Miraglia del Giudice

Original Articles

Growth hormone/insulin-like growth factor I axis, glucose metabolism, and lypolisis but not leptin show some degree of refractoriness to snort-term fasting in acromegaly

S. Grottoli, V. Gasco, A. Mainolfi, G. Beccuti, G. Corneli, G. Aimaretti, C. Dieguez, F. Casanueva, E. Ghigo

Original Articles

Effects of tea polyphenols on ovarian development in rats

L. L. Luo, J. Huang, Y. C. Fu, J. J. Xu, Y. S. Qian

Review Article

Autoimmunity as a possible cause of growth hormone deficiency

A. De Bellis, A. Colao, G. Tirelli, G. Ruocco, C. Di Somma, M. Battaglia, E. Pane, G. Bellastella, A. Dello lacovo, A. A. Sinisi, A. Bizzarro, A. Bellastella

Letter to the Editor

A case of severe occult ectopic adrenocorticotropin syndrome treated with retrograde venous adrenal ablation using ethanol

A. Gatti, M. G. Baroni, S. Romeo, E. Mandosi, M. Fallarino, M. Bezzi, L. Paciucci, S. Filetti, S. Morano

Letter to the Editor

Acute suppurative thyroiditis disclosing diagnosis of thyroid cancer in a boy

G. Crisafulli, M. Wasniewska, G. Ascenti, I. Rulli, G. Zirilli, T. Aversa, F. De Luca

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine